SCHEMBL8449983

SCHEMBL8449983

CCOC(=O)c1ccc2nn(CCCN3C(=O)c4ccccc4C3=O)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
NPSR1 Q6W5P4 4/20 0.47
TSHR P16473 3/20 0.47
HTT P42858 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 2/20 0.46
MAPK1 P28482 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PABPC1 P11940 2/20 0.45
APOBEC3A P31941 2/20 0.45
EIF4H Q15056 2/20 0.45
APOBEC3G Q9HC16 2/20 0.45
MAPT P10636 2/20 0.45
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28707196 0.79 ALDH1A1 (0.50) ALDH1A1NPSR1TSHRHTTCYP1A2
SCHEMBL29459506 0.79 ALDH1A1 (0.50) ALDH1A1NPSR1TSHRHTTCYP1A2
SCHEMBL14271511 0.79 NPC1 (0.45) ALDH1A1CYP1A2CYP3A4SMN1; SMN2LMNA
SCHEMBL904741 0.79 JMJD6 (0.53) ALDH1A1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL3436324 0.75 NPC1 (0.50) ALDH1A1SMN1; SMN2LMNAMAPTGAA
SCHEMBL4958588 0.73 PABPC1 (0.47) ALDH1A1NPSR1TSHRHTTCYP1A2
SCHEMBL9798847 0.72 GAA (0.64) ALDH1A1NPSR1SMN1; SMN2MAPK1MEN1
SCHEMBL9798916 0.72 TDP1 (0.58) ALDH1A1NPSR1TSHRHTTCYP1A2
SCHEMBL694601 0.71 GRM2 (0.48) ALDH1A1TSHRHTTSMN1; SMN2LMNA
SCHEMBL10965979 0.71 ALDH1A1 (0.48) ALDH1A1NPSR1TSHRHTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0939757-A1 NOVEL INTEGRIN RECEPTOR ANTAGONISTS Dupont Pharmaceuticals Company (US) 1999-09-08 EP disclosed
WO-1997023480-A1 NOVEL INTEGRIN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-07-03 WO disclosed